Detalles de la búsqueda
1.
Cytokine Release Syndrome Associated with T-Cell-Based Therapies for Hematological Malignancies: Pathophysiology, Clinical Presentation, and Treatment.
Int J Mol Sci
; 22(14)2021 Jul 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34299273
2.
Citarinostat and Momelotinib co-target HDAC6 and JAK2/STAT3 in lymphoid malignant cell lines: a potential new therapeutic combination.
Apoptosis
; 25(5-6): 370-387, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32394008
3.
Improving the international prognostic index score using peripheral blood counts: Results of a large multicenter study involving 520 patients with diffuse large B cell lymphoma.
Hematol Oncol
; 38(4): 439-445, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32495944
4.
The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of Pet-guided treatments.
Ann Hematol
; 99(2): 277-282, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31872362
5.
Nail StrainStress Meter NM 100: A novel in vivo method to characterize biomechanical properties of nails.
Skin Res Technol
; 26(3): 422-430, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31802538
6.
Ricolinostat, a selective HDAC6 inhibitor, shows anti-lymphoma cell activity alone and in combination with bendamustine.
Apoptosis
; 22(6): 827-840, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28315173
7.
Neutrophil-lymphocyte ratio at diagnosis is an independent prognostic factor in patients with nodular sclerosis Hodgkin lymphoma: results of a large multicenter study involving 990 patients.
Hematol Oncol
; 35(4): 561-566, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27791277
8.
A Multicenter Phase II Study of Twice-Weekly Bortezomib plus Rituximab in Patients with Relapsed Follicular Lymphoma: Long-Term Follow-Up.
Acta Haematol
; 137(1): 7-14, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-27820922
9.
Hexamermis popilliae n. sp. (Nematoda: Mermithidae) parasitizing the Japanese beetle Popillia japonica Newman (Coleoptera: Scarabaeidae) in Italy.
Syst Parasitol
; 94(8): 915-926, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28815424
10.
Correction to: The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of pet-guided treatments.
Ann Hematol
; 100(1): 303-304, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33219839
11.
The combination of bortezomib with enzastaurin or lenalidomide enhances cytotoxicity in follicular and mantle cell lymphoma cell lines.
Hematol Oncol
; 33(4): 166-75, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25394177
12.
Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre- and post-rituximab era.
Haematologica
; 99(1): 125-30, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23935023
13.
Survival of multiple myeloma patients in the era of novel therapies confirms the improvement in patients younger than 75 years: a population-based analysis.
Br J Haematol
; 163(1): 40-6, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23889344
14.
Absolute monocyte count at diagnosis could improve the prognostic role of early FDG-PET in classical Hodgkin lymphoma patients.
Br J Haematol
; 180(4): 600-602, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27785782
15.
Clinicopathological, cytogenetic, and molecular profiles of primary cutaneous diffuse large B-cell lymphomas.
Hum Pathol
; 136: 44-55, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36997030
16.
Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia: an effective but myelosuppressive regimen to be offered to patients with advanced disease.
Cancer
; 118(2): 434-43, 2012 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21732338
17.
Combination of low doses of enzastaurin and lenalidomide has synergistic activity in B-non-Hodgkin lymphoma cell lines.
Ann Hematol
; 91(10): 1613-22, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22623160
18.
New occurrence of Meloidogyne graminicola (Nematoda: Meloidogyninae) from rice fields in Italy: Variability and phylogenetic relationships.
Ecol Evol
; 12(9): e9326, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-36188499
19.
Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi.
Haematologica
; 101(5): e196-9, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26858355
20.
Dialysis-dependent renal failure at diagnosis continues to be associated with very poor outcome in multiple myeloma--response to Murphy et al.
Br J Haematol
; 165(6): 892, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24601955